Quercus Biosolutions has raised $5 million to develop AI-driven designer proteins for effective weed management, addressing challenges of herbicide resistance.
Quercus Biosolutions, an agricultural biotech startup, has successfully closed a $5 million seed funding round, which was oversubscribed and primarily led by Serra Ventures. The funding round attracted a diverse group of investors including Starshot Capital, Grantham Foundation for the Protection of the Environment, Flyover Capital, Rootstock Capital, and several other agriculture-focused funds.
Quercus aims to address the growing problem of herbicide resistance and the limitations of traditional chemical herbicides by utilizing artificial intelligence (AI). The company, founded in 2024 by industry veterans Jon Lightner, PhD, and Matt Crisp, is leveraging AI tools originally developed for drug discovery in collaboration with their partner, Ordaos Bio. Their goal is to design novel proteins that target specific biological components in weeds and other pests.
Innovative Protein Solutions Against Resistance
Resistance to conventional herbicides poses a significant challenge for growers. Traditional crop protection products have seen diminishing effectiveness, compelling farmers to navigate a shrinking array of reliable herbicide options. Lightner explains that Quercus focuses on existing validated biological targets, such as enzymes essential for plant growth. Their approach utilizes protein-protein interactions, which differ fundamentally from traditional chemical herbicides that rely on small molecules. By employing these designer proteins, Quercus can potentially bypass issues of evolved resistance found in conventional chemical approaches.
“We’re trying to build broad solutions that control multiple problem weeds in the field,” Lightner said, emphasizing the intent to meet growers' needs amidst the tightening efficacy of alternative options. He pointed out that growers are facing increasing demands for effective weed management while also responding to regulatory and market shifts favoring cleaner products.
Driving Research and Development
To streamline research and development (R&D) and reduce production costs, Quercus integrates manufacturability into the design phase of its proteins. The firm is partnering with specialists in precision fermentation to develop microbes capable of producing these designer proteins efficiently. This strategy aims to simplify the downstream processing by excreting the proteins into the fermentation broth, negating the need to disrupt cells for extraction, which typically increases costs and complexity.
This round of capital enables Quercus to not only increase the variety of targets for its herbicide program but also expand its intellectual property portfolio and explore applications for its technology beyond weed control to tackle fungi, insects, and other agricultural pests.
Market Strategy and Advancement Stages
Regarding market strategy, Lightner suggests a multifaceted approach involving collaborations with both major crop input companies and regional entities that have direct farmer engagement, such as retail cooperatives. This diversified pathway aims to facilitate product accessibility and distribution in various farming communities.
Matt Crisp, co-founder, noted the transition Quercus is making into what he describes as a “translational stage.” With the latest funding, the company plans to initiate regulatory processes and advance at least one product towards late-stage development, enhancing its readiness for market introduction.
Crisp also remarked on the scalability of their protein production, which can be conducted using simple organisms like E. coli or Pichia without undergoing any post-translational modifications, thus ensuring a more economical and straightforward production method. Numerous third-party assessments are underway to evaluate cost-efficiency and scalability, adding depth to their operational capabilities.
Investor Perspectives and Market Context
Rob Schultz, managing partner at lead investor Serra Ventures, reflected on the firm's cautious historical approach to investing in agricultural inputs, particularly due to uncertainties surrounding the costs and timelines associated with discovering new chemistry or biology. However, Quercus’ innovative approach utilizing generative AI has shifted this perspective. Schultz stated that the company demonstrated significant achievements in plant uptake and mobility, and that their rapid design-iteration process allowed them to move from concept to candidate efficiently.
“This speed on their first target signaled to us that their platform could generalize across multiple programs rather than rebuild from scratch each time,” he expressed. “We were drawn to the uniqueness of their platform and the pressing market need for innovation.”
Dan Kerr of Flyover Capital echoed these sentiments, highlighting Quercus’ ability to blend early technical progress with a knowledgeable team capable of transforming that groundwork into real-world products.
Future of Crop Protection with AI-Designed Proteins
Several companies in the agricultural biological sector have begun shifting toward the use of mini proteins or micropeptides due to their enhanced stability and precision. Most firms typically rely on libraries of natural proteins to identify effective candidates. In contrast, Quercus is taking a groundbreaking path by employing AI to create mini proteins from the ground up. “We look at all possible proteins, model their structures, and perform rapid testing to identify effective candidates,” Lightner explained.
The goal is to establish a substantial new crop protection category founded entirely on these custom proteins while maintaining the desirable regulatory and environmental characteristics associated with biological products, along with the proven efficacy of traditional chemical solutions.
With their innovative approach and a strong backing from experienced investors, Quercus is poised to make significant strides in enhancing crop protection strategies in the face of evolving agricultural challenges.
Further reading:
Moa Technology raises $30m to advance novel modes of action in weed management
